It was noteworthy that liquid-PRF demonstrated a significantly higher ability to promote the biological differentiation and mineralization of hPDLCs comparedwithPRP.
2
The PRIDE study aimed to assess the efficacy and safety of ranibizumab with or without PRP comparedwithPRP alone in patients with PDR.